trending Market Intelligence /marketintelligence/en/news-insights/trending/zXujBGk-0Dnn2_MCya9QmA2 content esgSubNav
In This List

Knight Therapeutics ups stake in Crescita

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Knight Therapeutics ups stake in Crescita

Knight Therapeutics Inc. upped its stake in Crescita Therapeutics Inc. by 4% to 14.9%.

The company acquired 566,471 new Crescita shares and continues to hold 396,000 warrants, which, if fully exercised, will increase its stake by an additional 2.3%.

The new shares were issued as part of an agreement dated Aug. 31, 2016.

Knight now owns a total of 2,079,973 Crescita shares, which are held for investment purposes.